Gene therapy trial offers hope for hemophilia a patients
NCT ID NCT07226206
First seen Nov 10, 2025 · Last updated May 20, 2026 · Updated 30 times
Summary
This study is testing a new gene therapy called SPK-8011QQ in adult men with severe or moderately severe hemophilia A, a bleeding disorder. The main goal is to see if the treatment is safe and tolerable. Only 5 participants will be enrolled, and they will be monitored for side effects and lab changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Inherited Blood Disorders
RECRUITINGOrange, California, 92868-4748, United States
-
Kaiser Permanente
RECRUITINGVallejo, California, 94589-2441, United States
Conditions
Explore the condition pages connected to this study.